Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
InMed Pharmaceuticals (MWG.F) Q2 2025 Earnings
MWG.F
13
May
Confirmed
Q1 2023
Q4 2024
Q1 2025
Q2 2025
-3.5
-2.91
-2.32
-1.73
Details
Expected EPS
N/A
Actual EPS
-1.7336422
Surprise EPS
-1.73
Surprise Percent
+∞%
Description
InMed Pharmaceuticals (MWG.F) has reported earnings of -1.7336422 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login